Literature DB >> 16473645

Renal toxicities of chemotherapy.

Maja J A de Jonge1, Jaap Verweij.   

Abstract

Chemotherapeutic agents can produce a variety of acute and chronic organ toxicities. Since many antitumor drugs and their metabolites are cleared renally, the kidneys are vulnerable to injury. The drugs involved will determine the site of injury within the kidney, resulting in clinical manifestations ranging from an asymptomatic rise in serum creatinine to acute renal failure. The most common renal toxicities of chemotherapeutic agents are described.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16473645     DOI： 10.1053/j.seminoncol.2005.11.011

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


  11 in total

Review 1.  Tumor targeting via EPR: Strategies to enhance patient responses.

Authors:  Susanne K Golombek; Jan-Niklas May; Benjamin Theek; Lia Appold; Natascha Drude; Fabian Kiessling; Twan Lammers
Journal:  Adv Drug Deliv Rev       Date:  2018-07-19       Impact factor: 15.470

2.  Acute kidney injury in cancer patients and impedance cardiography-assisted renal replacement therapy: Experience from the onconephrology unit of a Chinese tertiary hospital.

Authors:  Tao Wang; Yan Zhang; Qingxia Li; Shumin Jia; Changjin Shi; Kai Niu; Bing Liu
Journal:  Exp Ther Med       Date:  2017-10-02       Impact factor: 2.447

3.  Subacute kidney injury in hospitalized patients.

Authors:  Tomoko Fujii; Shigehiko Uchino; Masanori Takinami; Rinaldo Bellomo
Journal:  Clin J Am Soc Nephrol       Date:  2013-12-05       Impact factor: 8.237

4.  Evaluation of [18F]CP18 as a Substrate-Based Apoptosis Imaging Agent for the Assessment of Early Treatment Response in Oncology.

Authors:  Sara Rapic; Christel Vangestel; Filipe Elvas; Jeroen Verhaeghe; Tim Van den Wyngaert; Leonie Wyffels; Patrick Pauwels; Steven Staelens; Sigrid Stroobants
Journal:  Mol Imaging Biol       Date:  2017-08       Impact factor: 3.488

5.  Tumor therapy with a urokinase plasminogen activator-activated anthrax lethal toxin alone and in combination with paclitaxel.

Authors:  Alexander N Wein; Shihui Liu; Yi Zhang; Andrew T McKenzie; Stephen H Leppla
Journal:  Invest New Drugs       Date:  2012-07-28       Impact factor: 3.850

6.  Chemotherapy-related complications in the kidneys and collecting system: an imaging perspective.

Authors:  Jemianne Bautista Jia; Chandana Lall; Temel Tirkes; Rajesh Gulati; Ramit Lamba; Scott C Goodwin
Journal:  Insights Imaging       Date:  2015-07-11

7.  Epidermal growth factor receptor inhibition with erlotinib partially prevents cisplatin-induced nephrotoxicity in rats.

Authors:  Yukihiro Wada; Masayuki Iyoda; Kei Matsumoto; Yuki Shindo-Hirai; Yoshihiro Kuno; Yasutaka Yamamoto; Taihei Suzuki; Tomohiro Saito; Ken Iseri; Takanori Shibata
Journal:  PLoS One       Date:  2014-11-12       Impact factor: 3.240

8.  Biologically Active α-Amino Amide Analogs and γδ T Cells-A Unique Anticancer Approach for Leukemia.

Authors:  Ahmed Al Otaibi; Subuhi Sherwani; Salma Ahmed Al-Zahrani; Eida Mohammed Alshammari; Wahid Ali Khan; Abdulmohsen Khalaf D Alsukaibi; Shahper Nazeer Khan; Mohd Wajid Ali Khan
Journal:  Front Oncol       Date:  2021-07-12       Impact factor: 6.244

Review 9.  The Use of Imaging in the Prediction and Assessment of Cancer Treatment Toxicity.

Authors:  Hossein Jadvar
Journal:  Diagnostics (Basel)       Date:  2017-07-20

10.  Evaluation of Basal Renal Function in Treatment-naïve Patients with Malignancy and Comparison with Age Matched Healthy Control.

Authors:  Sukanta Barai; Sanjay Gambhir; Suruchi Jain; Neeraj Rastogi
Journal:  World J Nucl Med       Date:  2016-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.